Inhibition of phosphodiesterase 5 reduces bone mass by suppression of canonical Wnt
signaling |
| |
Authors: | Y Gong C Y Xu J R Wang X H Hu D Hong X Ji W Shi H X Chen H B Wang X M Wu |
| |
Institution: | 1.Department of Pharmacology, School of
Medicine, Zhejiang University, Hangzhou 310058, China;2.Department of Orthopedics, Taizhou
Hospital, Linhai 317000, China;3.State Key Laboratory of Reproductive
Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China |
| |
Abstract: | Inhibitors of phosphodiesterase 5 (PDE5) are widely used to treat erectile
dysfunction and pulmonary hypertension in clinics. PDE5, cyclic guanosine
monophosphate (cGMP), and protein kinase G (PKG) are important components of the
non-canonical Wnt signaling. This study aimed to investigate the effect of PDE5
inhibition on canonical Wnt signaling and osteoblastogenesis, using both in
vitro cell culture and in vivo animal models. In the in
vitro experiments, PDE5 inhibition resulted in activation of cGMP-dependent
protein kinase 2 and consequent inhibition of glycogen synthase kinase
3β phosphorylation, destabilization of cytosolic
β-catenin and the ultimate suppression of canonical Wnt signaling and
reduced osteoblastic differentiation in HEK293T and C3H10T1/2 cells. In animal
experiments, systemic inhibition of PDE5 suppressed the activity of canonical Wnt
signaling and osteoblastogenesis in bone marrow-derived stromal cells, resulting in
the reduction of bone mass in wild-type adult C57B/6 mice, significantly
attenuated secreted Frizzled-related protein-1 (SFRP1) deletion-induced activation of
canonical Wnt signaling and excessive bone growth in adult
SFRP1−/− mice. Together, these results uncover a
hitherto uncharacterized role of PDE5/cGMP/PKG signaling in bone homeostasis
and provide the evidence that long-term treatment with PDE5 inhibitors at a high
dosage may potentially cause bone catabolism.In the canonical Wnt (Wnt/β-catenin (β-cat)) signaling
cascade, Wnt binds to Frizzled (Frz) receptors and the low-density lipoprotein
receptor-related protein (LRP) 5 or 6, thereby activating dishevelled, suppressing the
glycogen synthase kinase 3β (GSK3β) activity and inhibiting
phosphorylation of β-cat at Thr41, Ser37, and Ser33 sites. The stabilized
cytosolic β-cat enters the nucleus and consequently activates its
downstream target genes via lymphoid enhancer-binding factor-1 (Lef-1) and T-cell
factors.1, 2 This signaling is fine-tuned in part via a negative feedback
mechanism involving secreted and transmembrane Wnt inhibitors and activators, secreted
Frz-related proteins (SFRPs), and Dickkopf-1 (Dkk1).3, 4Canonical Wnt signaling is critical not only to bone development in embryogenesis but
also to the maintenance of bone mass during adult life.5 The initial evidence came from the discoveries that in humans
loss- or gain-of-function mutations in LRP5 were linked with the
osteoporosis-pseudoglioma syndrome and a high-bone-density syndrome,
respectively.6, 7, 8 Subsequent studies in mice showed
that Wnt signaling might promote ossification by inducing the differentiation of
bone-forming osteoblasts, suppressing the development of bone-resorbing osteoclasts, and
driving the differentiation of multi-potent stem cells toward an osteoblast cell
fate.9Non-canonical Wnt signaling is β-cat independent and consists of two main
pathways: the Rho small GTPases-mediated planar cell polarity pathway and the
Wnt/Ca2+ pathway,10
involved in various aspects of cell fate differentiation and cell movement.
Non-canonical Wnt signaling has profound effects on tissue morphogenesis in a variety of
vertebrate species.10 The potential role for
non-canonical Wnt signaling in bone formation has been investigated recently in limited
studies, which have shown that the non-canonical Wnt-Gαq/11-PKC pathway
operates in mammalian osteoprogenitors to promote osteoblast development, and that Wnt16
exhibits a stimulatory effect on bone metabolism.11,
12, 13
Nevertheless, the molecular events in the non-canonical Wnt signaling regulation of bone
development and homeostasis have yet to be further elucidated.Phosphodiesterases (PDEs) are a large family of enzymes that cleave cyclic nucleotides.
To date, 11 PDE subtypes have been identified, among which PDE5 has been most
extensively studied. PDE5, cyclic guanosine monophosphate (cGMP), and cGMP-dependent
protein kinase (PKG) are among the major components of the non-canonical Wnt signaling
pathway and are involved in the regulation of intracellular Ca2+
concentration.14, 15 It is now well established that PDE5 degrades
3''-5′- cGMP and its inhibition leads to an increase in intracellular cGMP
levels and activation of protein kinase G (PKG), resulting in a decrease in
Ca2+ influx and consequent relaxation of smooth muscles, which
produces the therapeutic effects in clinical erectile dysfunction (ED) and pulmonary
hypertension (PH).14 Currently, little is
known regarding the involvement of PDE5 in Wnt signaling regulation of bone formation
and homeostasis. The objective of this study was to determine the effect of PDE5
inhibition on canonical Wnt signaling and bone mass. |
| |
Keywords: | |
|
|